| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Published online before print November 30, 2007
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7β1-Integrin Deficiency




From the Departments of Pathology* and Physiology,
University of California, San Francisco, California; the Program of Developmental Neurobiology,
Institute of Molecular Medicine and Genetics, Department of Neurology, Medical College of Georgia, Augusta, Georgia; the Shriners Hospital and McGill University,
Montreal, Quebec, Canada; and the Department of Biochemistry and Molecular Biology,¶ University of British Columbia, Vancouver, British Columbia, Canada
Integrin-linked kinase (Ilk) is a serine/threonine kinase and an adaptor protein that links integrins to the actin cytoskeleton and to a number of signaling pathways involved in integrin action. We hypothesized that Ilk may act as an important effector of integrins in skeletal muscle, where these receptors provide a critical link between the sarcolemma and the extracellular matrix. Using the cre/lox system, we deleted Ilk from skeletal muscles of mice. The resulting mutants developed a progressive muscular dystrophy with multiple degenerating and regenerating muscle fibers, increased central nuclei, and endomysial fibrosis. These defects were widespread but were most severe near myofascial junctions where Ilk mutants showed displacement of focal adhesion-related proteins, including vinculin, paxillin, focal adhesion kinase, dystrophin, and the
7β1D-integrin subunits. Distal ends of mutant muscle fibers appeared irregular, and there was restructuring of the actin cytoskeleton. These findings resemble those seen in humans and mice lacking the
7-integrin subunit and suggest that Ilk may act as a cytoplasmic effector of
7β1-integrin in the pathogenesis of these deficiencies.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |